Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
27.30
+2.40 (9.64%)
Jul 28, 2025, 4:09 PM HKT
9.64%
Market Cap40.38B
Revenue (ttm)2.22B
Net Income (ttm)-1.32B
Shares Out1.03B
EPS (ttm)-1.34
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,336,600
Average Volume11,009,892
Open25.40
Previous Close24.90
Day's Range24.90 - 27.70
52-Week Range9.72 - 28.80
Beta0.60
RSI65.98
Earnings DateAug 27, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 2,578
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1877
Full Company Profile

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.